chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Pain in extremity, Rash
Clinical narrative: Rash, face, chin, neck, back, shoulder, arm and jaws face; Pain at injection (right); Pain legs and feet; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Mar-2021 and was forwarded to Moderna on 02-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain legs and feet), RASH (Rash, face, chin, neck, back, shoulder, arm and jaws face) and INJECTION SITE PAIN (Pain at injection (right)) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031220A and 031220A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-Jan-2021, the patient experienced PAIN IN EXTREMITY (Pain legs and feet). On 16-Feb-2021, the patient experienced INJECTION SITE PAIN (Pain at injection (right)). On 24-Feb-2021, the patient experienced RASH (Rash, face, chin, neck, back, shoulder, arm and jaws face). On 21-Jan-2021, PAIN IN EXTREMITY (Pain legs and feet) had resolved. At the time of the report, RASH (Rash, face, chin, neck, back, shoulder, arm and jaws face) and INJECTION SITE PAIN (Pain at injection (right)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster, Rash
Clinical narrative: shingles; severe rash on his right side(leg,pubic area,stomach area,back area,); painful rash only when touched; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (shingles), RASH (severe rash on his right side(leg,pubic area,stomach area,back area,)) and RASH (painful rash only when touched) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     Concurrent medical conditions included Benign prostatic hypertrophy and Emphysema since March 2018. Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) from 28-Feb-2021 to an unknown date and TRAMADOL from 28-Feb-2021 to an unknown date for Back injury, FINASTERIDE for Benign prostatic hyperplasia, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE, VILANTEROL TRIFENATATE (TRELEGY ELLIPTA) for an unknown indication.   On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Mar-2021, the patient experienced RASH (severe rash on his right side(leg,pubic area,stomach area,back area,)) and RASH (painful rash only when touched). On an unknown date, the patient experienced HERPES ZOSTER (shingles). At the time of the report, HERPES ZOSTER (shingles) outcome was unknown and RASH (severe rash on his right side(leg,pubic area,stomach area,back area,)) and RASH (painful rash only when touched) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 26-May-2021: Updated patient medical history ( Emphysema) and added event (shingles)
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Erythema, Fatigue, Flushing
Clinical narrative: night sweats; fever; fatigue; muscle ache; chills; really dizzy; felt flushed in the face; cheeks were red; cheeks were swollen; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (really dizzy), FLUSHING (felt flushed in the face), ERYTHEMA (cheeks were red), SWELLING FACE (cheeks were swollen) and NIGHT SWEATS (night sweats) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.  Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) and DEXLANSOPRAZOLE (DEXILANT) for an unknown indication.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced DIZZINESS (really dizzy), FLUSHING (felt flushed in the face), ERYTHEMA (cheeks were red), SWELLING FACE (cheeks were swollen) and CHILLS (chills). On an unknown date, the patient experienced NIGHT SWEATS (night sweats), PYREXIA (fever), FATIGUE (fatigue) and MYALGIA (muscle ache). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) ongoing since an unknown date for Adverse event, at a dose of UNK dosage form. At the time of the report, DIZZINESS (really dizzy), FLUSHING (felt flushed in the face), ERYTHEMA (cheeks were red) and SWELLING FACE (cheeks were swollen) had resolved and NIGHT SWEATS (night sweats), CHILLS (chills), PYREXIA (fever), FATIGUE (fatigue) and MYALGIA (muscle ache) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   On an unknown date, Blood pressure measurement: result-unknown. On an unknown date, Oxygen saturation: result-unknown.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Night sweats, Pyrexia, Swelling face
Clinical narrative: night sweats; fever; fatigue; muscle ache; chills; really dizzy; felt flushed in the face; cheeks were red; cheeks were swollen; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (really dizzy), FLUSHING (felt flushed in the face), ERYTHEMA (cheeks were red), SWELLING FACE (cheeks were swollen) and NIGHT SWEATS (night sweats) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.  Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) and DEXLANSOPRAZOLE (DEXILANT) for an unknown indication.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced DIZZINESS (really dizzy), FLUSHING (felt flushed in the face), ERYTHEMA (cheeks were red), SWELLING FACE (cheeks were swollen) and CHILLS (chills). On an unknown date, the patient experienced NIGHT SWEATS (night sweats), PYREXIA (fever), FATIGUE (fatigue) and MYALGIA (muscle ache). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) ongoing since an unknown date for Adverse event, at a dose of UNK dosage form. At the time of the report, DIZZINESS (really dizzy), FLUSHING (felt flushed in the face), ERYTHEMA (cheeks were red) and SWELLING FACE (cheeks were swollen) had resolved and NIGHT SWEATS (night sweats), CHILLS (chills), PYREXIA (fever), FATIGUE (fatigue) and MYALGIA (muscle ache) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   On an unknown date, Blood pressure measurement: result-unknown. On an unknown date, Oxygen saturation: result-unknown.
Sex: U
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Ten patients were administered with the Moderna Vaccine that had suffered a temperature; A spontaneous report was received from a pharmacist concerning a patient who received Moderna's COVID-19 vaccine that had suffered a temperature excursion (mRNA-1273) (product storage error).   The patients' medical history was not provided. No relevant concomitant medications were reported.  On 4 Mar 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: not provided route of administration :unknown ) for prophylaxis of COVID-19 infection.  The vials that were affected due to the temperature excursions(product storage error) and there were 10 patients administered the vaccine (product storage error).  Treatment details Information Not provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of product storage error was recovered.; Reporter's Comments: This report refers to a case of Product storage error for mRNA-1273, lot # unknwn with no associated AEs.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary mass, Chills, Headache, Myalgia
Clinical narrative: A very large lump in her left arm pit from her pec to her breast; Chills; Body aches; Horrible headache; This spontaneous case was reported by a health care professional and describes the occurrence of AXILLARY MASS (A very large lump in her left arm pit from her pec to her breast), CHILLS (Chills), MYALGIA (Body aches) and HEADACHE (Horrible headache) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced AXILLARY MASS (A very large lump in her left arm pit from her pec to her breast), CHILLS (Chills), MYALGIA (Body aches) and HEADACHE (Horrible headache). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, AXILLARY MASS (A very large lump in her left arm pit from her pec to her breast), CHILLS (Chills), MYALGIA (Body aches) and HEADACHE (Horrible headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Hyperhidrosis, Myalgia, Night sweats, Pain in extremity
Clinical narrative: chills; body aches; still felt a bit sluggish; sore arm; woke up with night sweats only not as severe as before; woke up sweating drenched wet in what she describes as "night sweats"; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), HYPERHIDROSIS (woke up with night sweats only not as severe as before), CHILLS (chills), MYALGIA (body aches) and SLUGGISHNESS (still felt a bit sluggish) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included CARVEDILOL, OLMESARTAN, SODIUM CITRATE ACID (ALBACIT), CLONAZEPAM and TRAZODONE for an unknown indication.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Feb-2021, the patient experienced NIGHT SWEATS (woke up sweating drenched wet in what she describes as "night sweats"). On 01-Mar-2021, the patient experienced HYPERHIDROSIS (woke up with night sweats only not as severe as before). On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm), CHILLS (chills), MYALGIA (body aches) and SLUGGISHNESS (still felt a bit sluggish). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at a dose of UNK dosage form, qd. At the time of the report, PAIN IN EXTREMITY (sore arm), HYPERHIDROSIS (woke up with night sweats only not as severe as before), CHILLS (chills), MYALGIA (body aches), SLUGGISHNESS (still felt a bit sluggish) and NIGHT SWEATS (woke up sweating drenched wet in what she describes as "night sweats") outcome was unknown.            The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable
Sex: F
Vaccine: COVID19
Symptoms: Sluggishness
Clinical narrative: chills; body aches; still felt a bit sluggish; sore arm; woke up with night sweats only not as severe as before; woke up sweating drenched wet in what she describes as "night sweats"; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), HYPERHIDROSIS (woke up with night sweats only not as severe as before), CHILLS (chills), MYALGIA (body aches) and SLUGGISHNESS (still felt a bit sluggish) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included CARVEDILOL, OLMESARTAN, SODIUM CITRATE ACID (ALBACIT), CLONAZEPAM and TRAZODONE for an unknown indication.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Feb-2021, the patient experienced NIGHT SWEATS (woke up sweating drenched wet in what she describes as "night sweats"). On 01-Mar-2021, the patient experienced HYPERHIDROSIS (woke up with night sweats only not as severe as before). On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm), CHILLS (chills), MYALGIA (body aches) and SLUGGISHNESS (still felt a bit sluggish). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at a dose of UNK dosage form, qd. At the time of the report, PAIN IN EXTREMITY (sore arm), HYPERHIDROSIS (woke up with night sweats only not as severe as before), CHILLS (chills), MYALGIA (body aches), SLUGGISHNESS (still felt a bit sluggish) and NIGHT SWEATS (woke up sweating drenched wet in what she describes as "night sweats") outcome was unknown.            The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Joint injection
Clinical narrative: Cortisone Injection In Knee; This spontaneous case was reported by a consumer and describes the occurrence of JOINT INJECTION (Cortisone Injection In Knee) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced JOINT INJECTION (Cortisone Injection In Knee). At the time of the report, JOINT INJECTION (Cortisone Injection In Knee) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Chapped lips, Cheilitis, Lip infection
Clinical narrative: inflammation on her Lip; Cracked lip; Yellowish Discharge on her Lip; This spontaneous case was reported by a consumer and describes the occurrence of CHEILITIS (inflammation on her Lip), CHAPPED LIPS (Cracked lip) and LIP INFECTION (Yellowish Discharge on her Lip) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 81OTLIA) for COVID-19 vaccination.     Concurrent medical conditions included Hashimoto's disease since 2006 and Thyroid disorder. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced CHEILITIS (inflammation on her Lip), CHAPPED LIPS (Cracked lip) and LIP INFECTION (Yellowish Discharge on her Lip). At the time of the report, CHEILITIS (inflammation on her Lip), CHAPPED LIPS (Cracked lip) and LIP INFECTION (Yellowish Discharge on her Lip) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site rash
Clinical narrative: It turned into all red circle next day/ turned into red covid arm; It is still sore; covid arm; Rash at injection site that was 3 inch long circle; (Rash) itchy; Patient noticed pain in the whole upper left arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (covid arm), PAIN IN EXTREMITY (It is still sore), VACCINATION SITE PRURITUS ((Rash) itchy), VACCINATION SITE PAIN (Patient noticed pain in the whole upper left arm) and VACCINATION SITE RASH (Rash at injection site that was 3 inch long circle) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included IBUPROFEN (ADVIL HEADACHE & MIGRAINE) for an unknown indication.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 23-Feb-2021, the patient experienced VACCINATION SITE PAIN (Patient noticed pain in the whole upper left arm). On 02-Mar-2021, the patient experienced VACCINATION SITE PRURITUS ((Rash) itchy) and VACCINATION SITE RASH (Rash at injection site that was 3 inch long circle). On 03-Mar-2021, the patient experienced VACCINATION SITE REACTION (covid arm). On 05-Mar-2021, the patient experienced PAIN IN EXTREMITY (It is still sore). On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (It turned into all red circle next day/ turned into red covid arm). On 05-Mar-2021, VACCINATION SITE PAIN (Patient noticed pain in the whole upper left arm) outcome was unknown. At the time of the report, VACCINATION SITE REACTION (covid arm), PAIN IN EXTREMITY (It is still sore), VACCINATION SITE PRURITUS ((Rash) itchy), VACCINATION SITE RASH (Rash at injection site that was 3 inch long circle) and VACCINATION SITE ERYTHEMA (It turned into all red circle next day/ turned into red covid arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information provided. patient mentions "covid arm".   Most recent FOLLOW-UP information incorporated above includes: On 22-Mar-2021: Event reported-covid arm
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site reaction
Clinical narrative: It turned into all red circle next day/ turned into red covid arm; It is still sore; covid arm; Rash at injection site that was 3 inch long circle; (Rash) itchy; Patient noticed pain in the whole upper left arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (covid arm), PAIN IN EXTREMITY (It is still sore), VACCINATION SITE PRURITUS ((Rash) itchy), VACCINATION SITE PAIN (Patient noticed pain in the whole upper left arm) and VACCINATION SITE RASH (Rash at injection site that was 3 inch long circle) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included IBUPROFEN (ADVIL HEADACHE & MIGRAINE) for an unknown indication.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 23-Feb-2021, the patient experienced VACCINATION SITE PAIN (Patient noticed pain in the whole upper left arm). On 02-Mar-2021, the patient experienced VACCINATION SITE PRURITUS ((Rash) itchy) and VACCINATION SITE RASH (Rash at injection site that was 3 inch long circle). On 03-Mar-2021, the patient experienced VACCINATION SITE REACTION (covid arm). On 05-Mar-2021, the patient experienced PAIN IN EXTREMITY (It is still sore). On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (It turned into all red circle next day/ turned into red covid arm). On 05-Mar-2021, VACCINATION SITE PAIN (Patient noticed pain in the whole upper left arm) outcome was unknown. At the time of the report, VACCINATION SITE REACTION (covid arm), PAIN IN EXTREMITY (It is still sore), VACCINATION SITE PRURITUS ((Rash) itchy), VACCINATION SITE RASH (Rash at injection site that was 3 inch long circle) and VACCINATION SITE ERYTHEMA (It turned into all red circle next day/ turned into red covid arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information provided. patient mentions "covid arm".   Most recent FOLLOW-UP information incorporated above includes: On 22-Mar-2021: Event reported-covid arm
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Vaccination site pain
Clinical narrative: Rash on the face; pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash on the face) and VACCINATION SITE PAIN (pain at the injection site) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included CARVEDILOL and LOSARTAN for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced RASH (Rash on the face) and VACCINATION SITE PAIN (pain at the injection site). The patient was treated with HYDROCORTISONE ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, RASH (Rash on the face) and VACCINATION SITE PAIN (pain at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Pruritus, Rash
Clinical narrative: lightheadedness; rash; itching; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (lightheadedness), RASH (rash) and PRURITUS (itching) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (lightheadedness), RASH (rash) and PRURITUS (itching). At the time of the report, DIZZINESS (lightheadedness), RASH (rash) and PRURITUS (itching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Rash erythematous, Rash pruritic, Vaccination site rash
Clinical narrative: developed a rash at the injection site a week after the first dose of the vaccine; rash is red; rash is itchy; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (developed a rash at the injection site a week after the first dose of the vaccine), RASH ERYTHEMATOUS (rash is red) and RASH PRURITIC (rash is itchy) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) and Cream for itching for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE RASH (developed a rash at the injection site a week after the first dose of the vaccine), RASH ERYTHEMATOUS (rash is red) and RASH PRURITIC (rash is itchy). At the time of the report, VACCINATION SITE RASH (developed a rash at the injection site a week after the first dose of the vaccine), RASH ERYTHEMATOUS (rash is red) and RASH PRURITIC (rash is itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Missed second vaccination dose.; A spontaneous report was received from a reporter a health care professional concerning a female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and missed second vaccination dose.  The patient's medication history was not provided. Concomitant medication list not provided.  On 14 Jan2021, prior to the onset of the events, the patient received the first of the two planned doses of mRNA-1273 (lot/batch not available) intramuscularly for prophylaxis  of COVID-19 infection.  The patient was due for a second vaccine on 11 Feb 2021, but was denied an appointment by the clinic nurse. Treatment information were not provided.  Action taken with mRNA-1273 in response to the events was unknown.  The outcome of the event, missed dose, was considered recovered/resolved on a unknown date.; Reporter's Comments: This report refers to a case of Product dose omission issue for mRNA-1273, lot # unknown, with no associated AEs.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Decreased appetite, Eye pain, Fatigue, Feeling of body temperature change
Clinical narrative: haven't had an appetite; I have been taking cat naps; I am so tired my eyes hurt; feeling queasy; feeling so tired; stomach isn't feeling right; feelings of being sick; stomach gets gassy; feeling cold and then hot and then cold again; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (stomach isn't feeling right), MALAISE (feelings of being sick), NAUSEA (feeling queasy), FLATULENCE (stomach gets gassy) and FEELING OF BODY TEMPERATURE CHANGE (feeling cold and then hot and then cold again) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032L20A and 003A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COPD since an unknown date, Hypertension since an unknown date and UTI since an unknown date. Concomitant products included PHENDIMETRAZINE HYDROCHLORIDE (ANORAN) for COPD, QUINAPRIL, HYDROCHLOROTHIAZIDE, ESTRADIOL VALERATE (ESTRADIOL [ESTRADIOL VALERATE]) and ACETYLSALICYLIC ACID (ASPIRIN 81) for an unknown indication.   On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Mar-2021, the patient experienced ABDOMINAL DISCOMFORT (stomach isn't feeling right), MALAISE (feelings of being sick), NAUSEA (feeling queasy), FLATULENCE (stomach gets gassy), FEELING OF BODY TEMPERATURE CHANGE (feeling cold and then hot and then cold again), FATIGUE (feeling so tired), SOMNOLENCE (I have been taking cat naps) and EYE PAIN (I am so tired my eyes hurt). On an unknown date, the patient experienced DECREASED APPETITE (haven't had an appetite). At the time of the report, ABDOMINAL DISCOMFORT (stomach isn't feeling right), MALAISE (feelings of being sick), NAUSEA (feeling queasy), FLATULENCE (stomach gets gassy), FEELING OF BODY TEMPERATURE CHANGE (feeling cold and then hot and then cold again), FATIGUE (feeling so tired), DECREASED APPETITE (haven't had an appetite), SOMNOLENCE (I have been taking cat naps) and EYE PAIN (I am so tired my eyes hurt) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-036367 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the evens, a causal relationship cannot be excluded.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Flatulence, Malaise, Nausea, Somnolence
Clinical narrative: haven't had an appetite; I have been taking cat naps; I am so tired my eyes hurt; feeling queasy; feeling so tired; stomach isn't feeling right; feelings of being sick; stomach gets gassy; feeling cold and then hot and then cold again; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (stomach isn't feeling right), MALAISE (feelings of being sick), NAUSEA (feeling queasy), FLATULENCE (stomach gets gassy) and FEELING OF BODY TEMPERATURE CHANGE (feeling cold and then hot and then cold again) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032L20A and 003A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COPD since an unknown date, Hypertension since an unknown date and UTI since an unknown date. Concomitant products included PHENDIMETRAZINE HYDROCHLORIDE (ANORAN) for COPD, QUINAPRIL, HYDROCHLOROTHIAZIDE, ESTRADIOL VALERATE (ESTRADIOL [ESTRADIOL VALERATE]) and ACETYLSALICYLIC ACID (ASPIRIN 81) for an unknown indication.   On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Mar-2021, the patient experienced ABDOMINAL DISCOMFORT (stomach isn't feeling right), MALAISE (feelings of being sick), NAUSEA (feeling queasy), FLATULENCE (stomach gets gassy), FEELING OF BODY TEMPERATURE CHANGE (feeling cold and then hot and then cold again), FATIGUE (feeling so tired), SOMNOLENCE (I have been taking cat naps) and EYE PAIN (I am so tired my eyes hurt). On an unknown date, the patient experienced DECREASED APPETITE (haven't had an appetite). At the time of the report, ABDOMINAL DISCOMFORT (stomach isn't feeling right), MALAISE (feelings of being sick), NAUSEA (feeling queasy), FLATULENCE (stomach gets gassy), FEELING OF BODY TEMPERATURE CHANGE (feeling cold and then hot and then cold again), FATIGUE (feeling so tired), DECREASED APPETITE (haven't had an appetite), SOMNOLENCE (I have been taking cat naps) and EYE PAIN (I am so tired my eyes hurt) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-036367 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the evens, a causal relationship cannot be excluded.
Age: 99.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Groin pain, Hypersomnia, Malaise
Clinical narrative: Sleeping and sleeping; Feels some pain in my groin; Trouble getting off the couch; Extremely extremely extremely tired; A spontaneous report (United States) was received from a consumer concerning a 99-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events sleeping and sleeping, extremely extremely extremely tired, trouble getting off the couch, feels some pain in my groin.  The patient's medical history was not provided. Concomitant medications reported were codeine, pregablin for drug use for unknown indication.  On 5 Mar 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 030A21A) intramuscularly in the left deltoid for prophylaxis of COVID-19 infection.  On 5 Mar 2021, the patient experienced the events sleeping and sleeping, extremely extremely extremely tired, trouble getting off the couch, feels some pain in my groin.Consent given for safety to contact patient.  Treatment details not provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events, sleeping and sleeping, extremely extremely extremely tired, trouble getting off the couch, feels some pain in my groin was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Fall, Fatigue, Headache, Injection site pain
Clinical narrative: Fatigued; Dizzy; when the vertigo hits, I'm down; 3-4 episodes of vertigo on Thursday; have had headache since then; almost fell down a flight of stairs; Stood up and fell down; headache at the back of my head; 6 episodes of vertigo on Wednesday; threw up twice after 1st episode of vertigo; Arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of FALL (Stood up and fell down), INJECTION SITE PAIN (Arm was sore), HEADACHE (headache at the back of my head), VERTIGO (6 episodes of vertigo on Wednesday) and VOMITING (threw up twice after 1st episode of vertigo) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Lymphoma. Concomitant products included DULOXETINE and OMEPRAZOLE for an unknown indication.    On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced INJECTION SITE PAIN (Arm was sore). On 03-Mar-2021, the patient experienced FALL (Stood up and fell down), HEADACHE (headache at the back of my head), VERTIGO (6 episodes of vertigo on Wednesday), VOMITING (threw up twice after 1st episode of vertigo), HEADACHE (have had headache since then) and FALL (almost fell down a flight of stairs). On 04-Mar-2021, the patient experienced VERTIGO (3-4 episodes of vertigo on Thursday). On 05-Mar-2021, the patient experienced FATIGUE (Fatigued), DIZZINESS (Dizzy) and VERTIGO (when the vertigo hits, I'm down). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, FALL (Stood up and fell down), INJECTION SITE PAIN (Arm was sore), HEADACHE (headache at the back of my head), VERTIGO (6 episodes of vertigo on Wednesday), VOMITING (threw up twice after 1st episode of vertigo), FATIGUE (Fatigued), DIZZINESS (Dizzy), HEADACHE (have had headache since then), FALL (almost fell down a flight of stairs), VERTIGO (3-4 episodes of vertigo on Thursday) and VERTIGO (when the vertigo hits, I'm down) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: M
Vaccine: COVID19
Symptoms: Vertigo, Vomiting
Clinical narrative: Fatigued; Dizzy; when the vertigo hits, I'm down; 3-4 episodes of vertigo on Thursday; have had headache since then; almost fell down a flight of stairs; Stood up and fell down; headache at the back of my head; 6 episodes of vertigo on Wednesday; threw up twice after 1st episode of vertigo; Arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of FALL (Stood up and fell down), INJECTION SITE PAIN (Arm was sore), HEADACHE (headache at the back of my head), VERTIGO (6 episodes of vertigo on Wednesday) and VOMITING (threw up twice after 1st episode of vertigo) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Lymphoma. Concomitant products included DULOXETINE and OMEPRAZOLE for an unknown indication.    On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced INJECTION SITE PAIN (Arm was sore). On 03-Mar-2021, the patient experienced FALL (Stood up and fell down), HEADACHE (headache at the back of my head), VERTIGO (6 episodes of vertigo on Wednesday), VOMITING (threw up twice after 1st episode of vertigo), HEADACHE (have had headache since then) and FALL (almost fell down a flight of stairs). On 04-Mar-2021, the patient experienced VERTIGO (3-4 episodes of vertigo on Thursday). On 05-Mar-2021, the patient experienced FATIGUE (Fatigued), DIZZINESS (Dizzy) and VERTIGO (when the vertigo hits, I'm down). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, FALL (Stood up and fell down), INJECTION SITE PAIN (Arm was sore), HEADACHE (headache at the back of my head), VERTIGO (6 episodes of vertigo on Wednesday), VOMITING (threw up twice after 1st episode of vertigo), FATIGUE (Fatigued), DIZZINESS (Dizzy), HEADACHE (have had headache since then), FALL (almost fell down a flight of stairs), VERTIGO (3-4 episodes of vertigo on Thursday) and VERTIGO (when the vertigo hits, I'm down) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Overweight, Rhinorrhoea, SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: I feel overweight; Not sure if I got COVID due to the vaccine or not; I only had a runny nose and blowing my nose a little more then normal.; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (Not sure if I got COVID due to the vaccine or not), RHINORRHOEA (I only had a runny nose and blowing my nose a little more then normal.) and OVERWEIGHT (I feel overweight) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016MZ0M) for COVID-19 vaccination.     The patient's past medical history included Stroke and Aortic bypass.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Feb-2021, the patient experienced SARS-COV-2 TEST POSITIVE (Not sure if I got COVID due to the vaccine or not) and RHINORRHOEA (I only had a runny nose and blowing my nose a little more then normal.). On an unknown date, the patient experienced OVERWEIGHT (I feel overweight). At the time of the report, SARS-COV-2 TEST POSITIVE (Not sure if I got COVID due to the vaccine or not), RHINORRHOEA (I only had a runny nose and blowing my nose a little more then normal.) and OVERWEIGHT (I feel overweight) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Feb-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant information provided. No treatment information provided.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Influenza like illness
Clinical narrative: Worst flu like symptoms; Felt terrible; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Worst flu like symptoms) and FEELING ABNORMAL (Felt terrible) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029L20A and 215M20A) for COVID-19 vaccination.     Concomitant products included BUPROPION for an unknown indication.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 14-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (Worst flu like symptoms) and FEELING ABNORMAL (Felt terrible). On 15-Feb-2021, INFLUENZA LIKE ILLNESS (Worst flu like symptoms) and FEELING ABNORMAL (Felt terrible) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medication was reported.  Patient gave consent to safety for Follow-up.
Sex: F
Vaccine: COVID19
Symptoms: Conjunctivitis, Ocular discomfort
Clinical narrative: both of her eyes blew up after a few days; looked like conjunctivitis; This spontaneous case was reported by a consumer and describes the occurrence of OCULAR DISCOMFORT (both of her eyes blew up after a few days) and CONJUNCTIVITIS (looked like conjunctivitis) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced OCULAR DISCOMFORT (both of her eyes blew up after a few days) and CONJUNCTIVITIS (looked like conjunctivitis). At the time of the report, OCULAR DISCOMFORT (both of her eyes blew up after a few days) and CONJUNCTIVITIS (looked like conjunctivitis) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medication was reported.  Treatment information was not provided.  Upon internal review on 21-May-2021, the age was corrected to unknown.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Dizziness, Dysphagia, Dyspnoea
Clinical narrative: difficulty breathing; difficulty eating; difficulty swallowing; Lightheadedness; A spontaneous report (United States) was received from a consumer concerning a 34-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events difficulty breathing, eating, swallowing, and lightheadedness.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 24 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 016M20A) intramuscularly in the right arm for prophylaxis of COVID-19 infection.  On 24 Feb 2021, the patient experienced the events difficulty breathing, eating, swallowing, and lightheadedness, she had no problem breathing.  Treatment information was not provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events difficulty breathing, eating, swallowing, and lightheadedness, no problem breathing was unknown.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus
Clinical narrative: itchiness at injection site; redness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itchiness at injection site) and VACCINATION SITE ERYTHEMA (redness at injection site) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003A21A and 011M20A) for COVID-19 vaccination.     Concomitant products included TELMISARTAN, AMLODIPINE and ATORVASTATIN for an unknown indication.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (itchiness at injection site) and VACCINATION SITE ERYTHEMA (redness at injection site). At the time of the report, VACCINATION SITE PRURITUS (itchiness at injection site) and VACCINATION SITE ERYTHEMA (redness at injection site) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Updated event outcome and further FU was refused
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: extremely tired; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of FATIGUE (extremely tired) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FATIGUE (extremely tired). At the time of the report, FATIGUE (extremely tired) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment information was provided. No relevant concomitant medications reported   Reporter did not allow further contact
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Ear infection
Clinical narrative: Ear infection; This spontaneous case was reported by a consumer and describes the occurrence of EAR INFECTION (Ear infection) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EAR INFECTION (Ear infection). At the time of the report, EAR INFECTION (Ear infection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications reported.  Treatment medication including Antibiotics.  The caller returned the call stating MOD21-037044 was not referred to her. Her case number was MOD21-047472.   Most recent FOLLOW-UP information incorporated above includes: On 12-Jul-2021: Follow-up received on 12-JUL-2021 contains no significant information
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication, Vaccination site pain, Vaccination site swelling
Clinical narrative: it feels like arthritis; ARM IS SORE; Arm swelling; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (ARM IS SORE), VACCINATION SITE SWELLING (Arm swelling) and VACCINATION COMPLICATION (it feels like arthritis) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Mar-2021, the patient experienced VACCINATION SITE PAIN (ARM IS SORE) and VACCINATION SITE SWELLING (Arm swelling). On an unknown date, the patient experienced VACCINATION COMPLICATION (it feels like arthritis). The patient was treated with DIPHENHYDRAMINE, PARACETAMOL (EXTRA STRENGTH TYLENOL PM) for Pain, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PAIN (ARM IS SORE), VACCINATION SITE SWELLING (Arm swelling) and VACCINATION COMPLICATION (it feels like arthritis) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication provided.